Yesterday, the Texas Department of Public Safety (DPS) Regulatory Services Division (RSD) announced it would begin accepting new applications for medical cannabis dispensaries in Texas, under the Lone Star State’s Compassionate Use Program. The application window will run until 5:00 p.m. CT on April 28, 2023, and the application form can be submitted through the RSD Contact US portal

Texas, through Senate Bill 339, passed the Texas Compassionate Use legislation in 2015. That program allows certain qualified physicians to prescribe low THC products (max of 1% THC by weight) to patients having certain medical conditions. Currently, the state has only licensed three entities across the state as “dispensing organizations” to cultivate, process, and dispense low-THC cannabis. While yesterday’s announcement signals more dispensaries will receive licenses, DPS noted it would only issue “the number of licenses necessary to ensure reasonable statewide access to, and the availability, of low-THC cannabis for patients registered in the compassionate-use registry.” A decision on the number of licenses may not come until this summer so that the Texas Legislature has an opportunity to weigh in, something that could be in the works given the number of bills Texas lawmakers have recently filed related to cannabis reform. 

While Texas has a long way to go before it has a full-fledged medical cannabis program, things certainly appear to be moving in that direction. Surely, Texas won’t continue to be the only state in its region without a program and without that additional tax revenue. One thing’s for sure: Once that levee breaks, the Texas cannabis market will be a monster.

Photo of Slates C. Veazey Slates C. Veazey

Slates is a member of Bradley’s Cannabis Industry team, advising clients on a variety of cannabis issues and in a wide range of sectors. From individuals and entities interested in participating in the new Mississippi medical cannabis program to non-plant-touching companies impacted by…

Slates is a member of Bradley’s Cannabis Industry team, advising clients on a variety of cannabis issues and in a wide range of sectors. From individuals and entities interested in participating in the new Mississippi medical cannabis program to non-plant-touching companies impacted by that emerging market, Slates and his partners provide the full suite of services that Bradley offers to its many other clients — but with a specific understanding of the ever-changing cannabis industry. His work has been featured in The National Law Journal, JD Supra, and the Cannabis Business Executive. Slates also has been quoted by the Mississippi Business Journal and Mississippi Today regarding Mississippi’s medical cannabis program.